Beryl Capital Management’s Inozyme Pharma INZY Stock Holding History

Beryl Capital Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,321,584	Closed	-$25.3M	–	18
2025 Q2	$25.3M	Buy	+6,321,584	New	+$15.7M	3.81%	8

Beryl Capital Management's INZY Position: Q3 2025 in Review

Beryl Capital Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 6,321,584 shares — an estimated $25.3M sold.

Beryl Capital Management first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $25.3M in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Beryl Capital Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Beryl Capital Management sold 6,321,584 Inozyme Pharma shares in Q3 2025, an estimated $25.3M.
Beryl Capital Management first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Beryl Capital Management's Inozyme Pharma position peaked at $25.3M in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Beryl Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.